Defibrillation threshold testing in patients with hypertrophic cardiomyopathy

PACE - Pacing and Clinical Electrophysiology

Volumn 33, Issue 11, 2010, Pages 1342-1346

  Roberts, Brett D ^a   Hood, Robert E ^a   Saba, Magdi M ^a   Dickfeld, Timm M ^a   Saliaris, Anastasios P ^a   Shorofsky, Stephen R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

defibrillation; hypertrophic cardiomyopathy; implantable cardioverter defibrillator testing

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANT; MALE; MEDICAL RECORD REVIEW; PATIENT SELECTION; RETROSPECTIVE STUDY; TREATMENT INDICATION;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; DEFIBRILLATORS, IMPLANTABLE; ECHOCARDIOGRAPHY; ELECTRIC COUNTERSHOCK; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 78349252075     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2010.02843.x     Document Type: Article

References (23)

1. Maron BJ, Shen WK, Link MS, Epstein AE, Almquist AK, Daubert JP, Bardy GH, et al,. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy. N Engl J Med 2000; 342: 365-373.
2. Day JD, Olshansky B, Moore S, Brown S, Stolen KQ, Lerew DR,. High defibrillation energy requirements are encountered rarely with modern dual-chamber implantable cardioverter-defibrillator systems. Europace 2008; 10: 347-350.
3. Schuger C, Ellenbogen KA, Faddis M, Knight BP, Yong P, Sample R,. Defibrillation energy requirements in an ICD population receiving cardiac resynchronization therapy. J Cardiovasc Electrophysiol 2006; 17: 247-250.
4. Russo AM, Sauer W, Gerstenfeld EP, Hsia HH, Lin D, Cooper JM, Dixit S, et al,. Defibrillation threshold testing: Is it really necessary at the time of implantable cardioverter-defibrillator insertion? Heart Rhythm 2005; 2: 456-461.
5. Epstein AE, Ellenbogen KA, Kirk KA, Kay GN, Dailey SM, Plumb VJ,. Clinical characteristics and outcome of patients with high defibrillation thresholds. A multicenter study. Circulation 1992; 86: 1206-1216.
6. Gold MR, Khalighi K, Kavesh NG, Daly B, Peters RW, Shorofsky SR,. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 1997; 79: 1623-1627. (Pubitemid 27339471)
7. Boriani G, Biffi M, Frabetti L, Maraschi M, Branzi A,. High defibrillation threshold at cardioverter defibrillator implantation under amiodarone treatment: Favorable effects of D, L-sotalol. Heart Lung 2000; 29: 412-416.
8. Khalighi K, Daly B, Leino EV, Shorofsky SR, Kavesh NG, Peters RW, Gold MR,. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 1997; 79: 150-153. (Pubitemid 127673701)
9. Lubinski A, Lewicka-Nowak E, Zienciuk A, Krolak T, Kempa M, Pazdyga A, Swiatecka G,. Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators. Kardiol Pol 2005; 62: 317-328; discussion 329-331.
10. Shukla HH, Flaker GC, Jayam V, Roberts D,. High defibrillation thresholds in transvenous biphasic implantable defibrillators: Clinical predictors and prognostic implications. Pacing Clin Electrophysiol 2003; 26: 44-48.
11. Pinski SL, Vanerio G, Castle LW, Morant VA, Simmons TW, Trohman RG, Wilcoff BL, et al,. Patients with a high defibrillation threshold: Clinical characteristics, management, and outcome. Am Heart J 1991; 122: 89-95.
12. Boriani G, Rapezzi C, Biffi M, Branzi A,. Hypertrophic cardiomyopathy with massive hypertrophy, amiodarone treatment and high defibrillation threshold at cardioverter-defibrillator implant. Int J Cardiol 2002; 83: 171-173.
13. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, et al,. ACC/AHA/HRS 2008 Guidelines for Device-based Therapy of Cardiac Rhythm Abnormalities. Heart Rhythm 2008; 5: e1-e62.
14. Leong-Sit P, Gula LJ, Diamantouros P, Krahn AD, Skanes AC, Yee R, Klein GJ,. Effect of defibrillation testing on management during implantable cardioverter-defibrillator implantation. Am Heart J 2006; 152: 1104-1108.
15. Shorofsky SR, Peters RW, Rashba EJ, Gold MR,. Comparison of step-down and binary search algorithms for determination of defibrillation threshold in humans. Pacing Clin Electrophysiol 2004; 27: 218-220.
16. Birnie D, Tung S, Simpson C, Crystal E, Exner D, Ayala Paredes FA, Krahn A, et al,. Complications associated with defibrillation threshold testing: The Canadian experience. Heart Rhythm 2008; 5: 387-390.
17. Niemann JT, Rosborough JP, Youngquist S, Thomas J, Lewis RJ,. Is all ventricular fibrillation the same? A comparison of is chemically induced with electrically induced ventricular fibrillation in a porcine cardiac arrest and resuscitation model. Crit Care Med 2007; 35: 1356-1361.
18. Lever NA, Newall EG, Larsen PD,. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007; 9: 1054-1058.
19. Makikallio TH, Huikuri HV, Myerburg RJ, Seppanen T, Kloosterman M, Interian A, Jr,., Castellanos A, et al,. Differences in the activation patterns between sustained and self-terminating episodes of human ventricular fibrillation. Ann Med 2002; 34: 130-135.
20. Bianchi S, Ricci RP, Biscione F, Sgreccia F, Di Belardino N, Rossi P, Giuli S, et al,. Primary prevention implantation of cardioverter defibrillator without defibrillation threshold testing: 2-year follow-up. Pacing Clin Electrophysiol 2009; 32: 573-578.
21. Blatt JA, Poole JE, Johnson GW, Callans DJ, Raitt MH, Reddy RK, Marchlinski FE, et al,. No benefit from defibrillation threshold testing in the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial). J Am Coll Cardiol 2008; 52: 551-556.
22. Nagai T, Kurita T, Satomi K, Noda T, Okamura H, Shimizu W, Suyama K, et al,. QRS prolongation is associated with high defibrillation thresholds during cardioverter-defibrillator implantations in patients with hypertrophic cardiomyopathy. Circ J 2009; 73: 1028-1032.
23. Leitch JW, Yee R,. Predictors of defibrillation efficacy in patients undergoing epicardial defibrillator implantation. The Multicenter Pacemaker-Cardioverter-Defibrillator (PCD) Investigators Group. J Am Coll Cardiol 1993; 21: 1632-1637.